IBDEI0HT ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,8658,1,3,0)
 ;;=3^Pemphigoid Bgn Mucous Membr w/ Ocular
 ;;^UTILITY(U,$J,358.3,8658,1,4,0)
 ;;=4^694.61
 ;;^UTILITY(U,$J,358.3,8658,2)
 ;;=^271915
 ;;^UTILITY(U,$J,358.3,8659,0)
 ;;=720.0^^58^612^85
 ;;^UTILITY(U,$J,358.3,8659,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8659,1,3,0)
 ;;=3^Spondylitis,Ankylosing
 ;;^UTILITY(U,$J,358.3,8659,1,4,0)
 ;;=4^720.0
 ;;^UTILITY(U,$J,358.3,8659,2)
 ;;=^113484
 ;;^UTILITY(U,$J,358.3,8660,0)
 ;;=743.10^^58^612^66
 ;;^UTILITY(U,$J,358.3,8660,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8660,1,3,0)
 ;;=3^Microphthalmos,Unspec
 ;;^UTILITY(U,$J,358.3,8660,1,4,0)
 ;;=4^743.10
 ;;^UTILITY(U,$J,358.3,8660,2)
 ;;=^77633
 ;;^UTILITY(U,$J,358.3,8661,0)
 ;;=996.89^^58^612^52
 ;;^UTILITY(U,$J,358.3,8661,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8661,1,3,0)
 ;;=3^Graft Rejection
 ;;^UTILITY(U,$J,358.3,8661,1,4,0)
 ;;=4^996.89
 ;;^UTILITY(U,$J,358.3,8661,2)
 ;;=^276309
 ;;^UTILITY(U,$J,358.3,8662,0)
 ;;=077.3^^58^612^26
 ;;^UTILITY(U,$J,358.3,8662,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8662,1,3,0)
 ;;=3^Conjunctivitis,Adenoviral
 ;;^UTILITY(U,$J,358.3,8662,1,4,0)
 ;;=4^077.3
 ;;^UTILITY(U,$J,358.3,8662,2)
 ;;=^266673
 ;;^UTILITY(U,$J,358.3,8663,0)
 ;;=077.99^^58^612^21
 ;;^UTILITY(U,$J,358.3,8663,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8663,1,3,0)
 ;;=3^Conjunctivitis d/t Virus,Unspec
 ;;^UTILITY(U,$J,358.3,8663,1,4,0)
 ;;=4^077.99
 ;;^UTILITY(U,$J,358.3,8663,2)
 ;;=^295786
 ;;^UTILITY(U,$J,358.3,8664,0)
 ;;=077.98^^58^612^9
 ;;^UTILITY(U,$J,358.3,8664,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8664,1,3,0)
 ;;=3^Conjuctivitis d/t Chlamydiae
 ;;^UTILITY(U,$J,358.3,8664,1,4,0)
 ;;=4^077.98
 ;;^UTILITY(U,$J,358.3,8664,2)
 ;;=^295785
 ;;^UTILITY(U,$J,358.3,8665,0)
 ;;=190.4^^58^612^40
 ;;^UTILITY(U,$J,358.3,8665,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8665,1,3,0)
 ;;=3^Cornea Malig Neopl
 ;;^UTILITY(U,$J,358.3,8665,1,4,0)
 ;;=4^190.4
 ;;^UTILITY(U,$J,358.3,8665,2)
 ;;=^267275
 ;;^UTILITY(U,$J,358.3,8666,0)
 ;;=V67.09^^58^613^22
 ;;^UTILITY(U,$J,358.3,8666,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8666,1,3,0)
 ;;=3^F/U Vitreous Surgery
 ;;^UTILITY(U,$J,358.3,8666,1,4,0)
 ;;=4^V67.09
 ;;^UTILITY(U,$J,358.3,8666,2)
 ;;=F/U Vitreous Surgery^322080^V45.69^V43.1
 ;;^UTILITY(U,$J,358.3,8667,0)
 ;;=367.4^^58^613^43
 ;;^UTILITY(U,$J,358.3,8667,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8667,1,3,0)
 ;;=3^Presbyopia
 ;;^UTILITY(U,$J,358.3,8667,1,4,0)
 ;;=4^367.4
 ;;^UTILITY(U,$J,358.3,8667,2)
 ;;=Presbyopia^98095
 ;;^UTILITY(U,$J,358.3,8668,0)
 ;;=379.21^^58^613^42
 ;;^UTILITY(U,$J,358.3,8668,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8668,1,3,0)
 ;;=3^Posterior Vitreous Detachment
 ;;^UTILITY(U,$J,358.3,8668,1,4,0)
 ;;=4^379.21
 ;;^UTILITY(U,$J,358.3,8668,2)
 ;;=^269309
 ;;^UTILITY(U,$J,358.3,8669,0)
 ;;=374.10^^58^613^20
 ;;^UTILITY(U,$J,358.3,8669,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8669,1,3,0)
 ;;=3^Ectropion
 ;;^UTILITY(U,$J,358.3,8669,1,4,0)
 ;;=4^374.10
 ;;^UTILITY(U,$J,358.3,8669,2)
 ;;=Ectropion^38326
 ;;^UTILITY(U,$J,358.3,8670,0)
 ;;=373.00^^58^613^8
 ;;^UTILITY(U,$J,358.3,8670,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8670,1,3,0)
 ;;=3^Blepharitis
 ;;^UTILITY(U,$J,358.3,8670,1,4,0)
 ;;=4^373.00
 ;;^UTILITY(U,$J,358.3,8670,2)
 ;;=Blepharitis^15271
 ;;^UTILITY(U,$J,358.3,8671,0)
 ;;=250.00^^58^613^13
 ;;^UTILITY(U,$J,358.3,8671,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8671,1,3,0)
 ;;=3^DM II w/o Eye Disease
 ;;^UTILITY(U,$J,358.3,8671,1,4,0)
 ;;=4^250.00
 ;;^UTILITY(U,$J,358.3,8671,2)
 ;;=DM Type II w/o Eye Disease^33605
